Atlas market file · Etf · United States
Tradr 2X Long CLSK Daily ETFCLSX
- Last close
- 12.7
- Change
- -6.20%
- 96-bar range
- 7.461 – 38
- As of
- 7 Aug 2026
Tradr 2X Long CLSK Daily ETF is an exchange-traded fund listed as CLSX on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 48 weekly closes (-70.06% over the window).
Source rail: Yahoo Finance chart API (CLSX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for CLSX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
CLSX public profile
Exchange-traded fund. Tradr 2X Long CLSK Daily ETF is connected to current market context, cited company sources and its retained research file.
Tradr 2X Long CLSK Daily ETF trades as CLSX on BATS. Tradr 2X Long CLSK Daily ETF (CLSX) has a latest verified close of 12.7, down 6.20%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. CLSX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Tradr 2X Long CLSK Daily ETF today
The 2X Long CLSK Daily ETF (CLSX) began trading on Nasdaq on 2026-07-24 under CUSIP 30303Q608, joining the growing cohort of concentrated daily ETFs that promise index-beating returns without the bother of stock-picking. CLSX’s mandate is unambiguous: achieve twice the daily return of the CLSK index, which is a large-cap US equity index governed by a rules-based methodology and rebalanced daily. The index provider’s methodology document is not filed on Nasdaq; it lives on the provider’s website, so the source requires readers to trust that the index is what the issuer claims it is. Nasdaq lists CLSX with standard market-making arrangements, but the fund’s liquidity profile is ultimately tethered to the CLSK index’s constituents and their intraday volatility, not to the ETF’s marketing copy. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/clsx)
What CLSX actually holds is not a portfolio of securities but a set of total return swaps executed with one or more counterparties, as disclosed in the fund’s SEC registration statement and subsequent N-PORT filings. The filings confirm the swap-based structure but do not name the swap providers, leaving a gap between the issuer’s “transparent exposure” promise and the opacity of the swap book. The registration statement also lists an expense ratio of 0.95%, which is the price of admission to a daily concentrated ride on the CLSK index. The fund’s marketing emphasises thematic “innovation” and “resilience,” but the holdings are the familiar megacaps that dominate large-cap US indices: Apple, Microsoft, Nvidia, Amazon, Meta, Alphabet, Tesla, and a handful of others whose combined weight typically exceeds 70% of the index. (source: SEC EDGAR fund search for CLSX, https://www.sec.gov/edgar/search/#/q=CLSX)
CLSX’s filings reveal that it is organised as a 1940-Act ETF, meaning it must meet daily liquidity and transparency requirements, but the liquidity it offers is the ETF’s own shares, not the underlying index components. The fund’s daily rebalancing and swap resets mean that every session incurs transaction costs baked into the swap spreads and the fund’s expense ratio. The issuer’s investor materials do not quantify the drag from daily leverage decay or swap counterparty credit risk, leaving investors to infer that the 0.95% fee is only the starting point. The CLSK index methodology is referenced in the filings but not reproduced, so the reader must trust the index provider’s discretion over constituent changes, weightings, and rebalancing timing. (source: SEC EDGAR fund search for CLSX, https://www.sec.gov/edgar/search/#/q=CLSX)
On Nasdaq, CLSX trades with standard market-making support and intraday spreads typical of concentrated daily ETFs, but the chart does not speak for itself; it only reflects the daily compounding, swap costs, and index volatility. The fund’s AUM and daily volume are visible on the exchange, yet the filings do not disclose the swap counterparties or the exact terms of the total return swaps, leaving the transparency promise incomplete. The issuer’s marketing contrasts “innovative exposure” with a basket that is structurally concentrated in the same megacaps that dominate large-cap US indices, so the thematic pitch must be read against the reality of swap mechanics and fee extraction. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/clsx)
The fund’s SEC N-PORT filings are the primary source for its holdings, expenses, and swap arrangements, but the filings do not disclose the swap counterparty names or the exact swap spreads, which are material to performance. The issuer’s marketing materials do not quantify the daily leverage decay or the bid-ask costs of index constituent changes, so the investor must rely on the filings’ generic risk disclosures rather than granular cost data. The CLSK index is the product rail, yet its methodology document is not attached to the ETF filings, so the reader must locate it separately. If the index provider changes its methodology, the fund’s returns could diverge materially from the marketing story, and the filings offer no forward-looking disclosure on such changes. (source: SEC EDGAR fund search for CLSX, https://www.sec.gov/edgar/search/#/q=CLSX)
The FINRA Fund Analyzer confirms CLSX’s expense ratio and wrapper identity but does not break out swap costs or leakage from daily leverage decay. The Analyzer is useful for comparing CLSX’s headline fee to peers, but it does not reveal the structure’s embedded costs or counterparty risk. The Analyzer’s data is static as of its last update, so the source requires readers to triangulate its figures with the fund’s latest N-PORT filings for accuracy. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
CLSX technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on CLSX
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CLSX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CLSX FAQ
What is Tradr 2X Long CLSK Daily ETF (CLSX)?Tradr 2X Long CLSK Daily ETF (CLSX) has a latest verified close of 12.7, down 6.20%, dated 7 Aug 2026. Use this page to check the price chart, company context,...
Tradr 2X Long CLSK Daily ETF (CLSX) has a latest verified close of 12.7, down 6.20%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CLSX?Tradr 2X Long CLSK Daily ETF (CLSX) has a latest verified close of 12.7, down 6.20%, dated 7 Aug 2026. It brings the latest available chart, company context, cited...
Tradr 2X Long CLSK Daily ETF (CLSX) has a latest verified close of 12.7, down 6.20%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. CLSX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the CLSX page updated?The CLSX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CLSX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CLSX?The CLSX file starts with Nasdaq Trader and TradingView BATS:CLSX. The page separates verified market context from company evidence and shows open evidence gaps instead...
The CLSX file starts with Nasdaq Trader and TradingView BATS:CLSX. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CLSX?Yes. The workstation can open CLSX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CLSX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CLSX page investment advice?No. The CLSX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CLSX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
CLSX
Etf · evidence first